These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25812656)

  • 1. Transglutaminase 2 expression and its prognostic significance in clear cell renal cell carcinoma.
    Park MJ; Baek HW; Rhee YY; Lee C; Park JW; Kim HW; Moon KC
    J Pathol Transl Med; 2015 Jan; 49(1):37-43. PubMed ID: 25812656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.
    Erdem S; Yegen G; Telci D; Yildiz I; Tefik T; Issever H; Kilicaslan I; Sanli O
    World J Urol; 2015 Oct; 33(10):1553-60. PubMed ID: 25515319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.
    Lee C; Park JW; Suh JH; Moon KC
    Pathol Res Pract; 2015 Nov; 211(11):824-8. PubMed ID: 26296917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGFR-1 Expression Relates to Fuhrman Nuclear Grade of Clear Cell Renal Cell Carcinoma.
    Lkhagvadorj S; Oh SS; Lee MR; Jung JH; Chung HC; Cha SK; Eom M
    J Lifestyle Med; 2014 Mar; 4(1):64-70. PubMed ID: 26064856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of tissue transglutaminase 2 in colon carcinoma.
    Fernández-Aceñero MJ; Torres S; Garcia-Palmero I; Díaz Del Arco C; Casal JI
    Virchows Arch; 2016 Dec; 469(6):611-619. PubMed ID: 27620315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.
    Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X
    BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
    BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of BAP1 in pT1 clear cell carcinoma in partial nephrectomy specimens.
    Minardi D; Lucarini G; Milanese G; Montironi R; Di Primio R
    Virchows Arch; 2017 Jul; 471(1):99-105. PubMed ID: 28488170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
    Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
    Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of PHF2 Expression in Clear Cell Renal Cell Carcinoma.
    Lee C; Kim B; Song B; Moon KC
    J Pathol Transl Med; 2017 Jul; 51(4):359-364. PubMed ID: 28607325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of CD44, matrix metalloproteinase2 and matrix metalloproteinase9 in renal cell carcinomas.
    Lee YM; Kim JM; Lee HJ; Seong IO; Kim KH
    Urol Oncol; 2019 Oct; 37(10):742-748. PubMed ID: 31053527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
    Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
    Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma.
    Bagatur Y; Ilter Akulke AZ; Bihorac A; Erdem M; Telci D
    Cell Adh Migr; 2018 Mar; 12(2):138-151. PubMed ID: 28498731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of nuclear BAP1 protein expression is a marker of poor prognosis in patients with clear cell renal cell carcinoma.
    Minardi D; Lucarini G; Milanese G; Di Primio R; Montironi R; Muzzonigro G
    Urol Oncol; 2016 Aug; 34(8):338.e11-8. PubMed ID: 27085487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma.
    Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
    PLoS One; 2016; 11(11):e0166231. PubMed ID: 27861513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A8 Expression May Have a Prognostic Value in CCRCC Reflecting TNM Staging and Fuhrman Nuclear Grade.
    An HJ; Koh HM; Song DH
    Anticancer Res; 2019 Sep; 39(9):4681-4685. PubMed ID: 31519567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.